Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating hypophosphatasia (HPP) in adults and adolescents

Methods for treating hypophosphatasia (HPP) in adults and adolescents

US Patent 11224637 · Granted Jan 18, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosage and administration of anti-C5 antibodies for treatment of atypical hemoly2025
Use of gene editing to generate universal TCR re-directed t cells for adoptive i2025
Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor 2024
BCMA targetting antibodies, chimeric antigen receptors, and uses thereof2024
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating can2024
Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor2023
Aryl-phosphorus-oxygen compound as EGFR kinase inhibitor2022
Use of gene editing to generate universal TCR re-directed T cells for adoptive i2021
Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating can2020
Administration of alpha4beta7 hetero-dimer-specific antibody2018
Method of treatment using fused aromatic compounds having anti-diabetic activity2012